Activation Capital accepts 10 start-ups in the inaugural Frontier BioHealth program
Each company benefits from highly specialized training, targeted mentorship, and extensive relationship-building opportunities to accelerate its growth.
Activation Capital, a Richmond, VA-based innovation ecosystem development organization, has announced the selection of 10 start-ups from across the country for the inaugural Frontier BioHealth program.
Frontier BioHealth by Activation Capital is an educational and support program designed to provide highly specialized training, targeted mentorship, and relationship building to help scale pharmaceutical, biotech, medical device, and health-focused consumer products companies. Each company benefits from highly specialized training, targeted mentorship, and extensive relationship-building opportunities to accelerate its growth in the life sciences and healthtech sectors.
The inaugural cohort includes:
- Atticus that has developed a sustained-release system for delivering therapeutics directly to the skin.
- GenAssist that has created MyoMatrix, a patented biomaterial that regrows muscle lost to disease or traumatic injury.
- Gisens Biotech, a provider of a saliva test that allows patients with chronic kidney disease (CKD) to monitor their health from the comfort of their home and receive personalized and timely care.
- KeViRx that is transforming acute lung injury patient care through the development of novel small molecule drugs.
- Light Switch Bio that is developing an approach for laser-targeted drug delivery to avoid side effects by using lasers to activate drugs only where they’re needed in the body.
- Oncoustics that creates advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need.
- OrthoPreserve, a provider of a meniscus replacement implant that improves quality of life for people with knee injuries involving the meniscus.
- Pele Therapeutics that is empowering the patient in vivo protein therapy revolution to treat devastating and debilitating metabolic and fibrotic diseases with safer, effective, and affordable gene/protein therapy.
- Rapid Forensic Cell Typing (RFCT) that is revolutionizing criminal investigations by providing law enforcement and crime labs with a SaaS platform that enables rapid identification and prioritization of forensic evidence.
- Vizma Life Sciences, a provider of a device that enables MRI scanners to directly visualize treatment response in days, rather than months.
Like what you've read?
Forward to a friend!